The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2020

Filed:

Jun. 04, 2018
Applicant:

Concievalve Llc, Minneapolis, MN (US);

Inventor:

Nalini M. Rajamannan, Chicago, IL (US);

Assignee:

CONCIEVALVE, LLC, Minneapolis, MN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/24 (2006.01); A61L 27/36 (2006.01); A61L 27/54 (2006.01); A61L 31/16 (2006.01); A61K 9/00 (2006.01); A61K 31/40 (2006.01); A61L 31/14 (2006.01); A61K 31/337 (2006.01);
U.S. Cl.
CPC ...
A61L 27/3625 (2013.01); A61F 2/2412 (2013.01); A61K 9/0024 (2013.01); A61K 31/337 (2013.01); A61K 31/40 (2013.01); A61L 27/54 (2013.01); A61L 31/14 (2013.01); A61L 31/16 (2013.01); A61F 2/2418 (2013.01); A61F 2250/0067 (2013.01); A61L 2300/204 (2013.01); A61L 2300/21 (2013.01); A61L 2300/258 (2013.01); A61L 2300/416 (2013.01); A61L 2300/606 (2013.01); A61L 2400/02 (2013.01); A61L 2430/20 (2013.01);
Abstract

Methods for inhibiting stenosis, obstruction and/or calcification of a heart valve following implantation in a vessel having a wall are disclosed. In one aspect the method includes providing a bioprosthetic heart valve mounted on an elastical stent; treating the bioprosthetic heart valve with a tissue fixative; coating the stent and the bioprosthetic valve with a coating composition including one or more therapeutic agents; implanting the bioprosthetic valve into the vessel in a diseased natural valve site; eluting the coating composition from the bioprosthetic valve; and inhibiting stenosis, obstruction and/or calcification of the bioprosthetic heart valve by preventing the attachment of stem cells to the bioprosthetic heart valve, the stem cells circulating external and proximate to the bioprosthetic heart valve by activating nitric oxide production (i) in the circulating stem cells, (ii) in an endothelial cell lining covering the bioprosthetic heart valve tissue, (iii) or both.


Find Patent Forward Citations

Loading…